FDA Must Cough Up Gilead Hep C Docs, Health Groups Say
Two public health groups sued the U.S. Food and Drug Administration in Connecticut federal court Friday, demanding access to information Gilead Sciences Inc. submitted for approval of its controversial hepatitis C...To view the full article, register now.
Already a subscriber? Click here to view full article